Vertex Pharma scientist talks about the long road to developing non
Time:2024-04-30 02:19:17 Source:worldViews(143)
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
You may also like
- Beijing warns of heavy catkin season on way
- US says China helping Moscow in biggest defence expansion since Soviet era
- Big, expensive, and not fit for purpose: What you need to know about Premier House
- ‘Corrosive obsession with a person’s race’: David Seymour on Māori Wards
- Thailand gears up for the return of Chinese travelers
- The Week in Politics: Coalition negotiations could be near the endgame
- Watch: PM Christopher Luxon speaks at first post
- More videos of Kiwi hostage Philip Mehrtens in Papua warn against Indonesian military air strikes
- Gemma Collins reunites with her former TOWIE co